Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Visual illustration of inside of lungs infected with COVID.

A Nature Communications study led by Professor Ling-Pei Ho’s group in the MRC Translational Immune Discovery Unit (TIDU) provides new insights into how immune cells interact in the lungs of patients with severe COVID-19. 

In a damaged lung with a massive cell infiltrate, as seen with severe COVID-19 infection, it can be difficult to figure out which cells are involved in causing lung injury. Understanding this provides a first step to identifying the cells or pathways that can be targeted therapeutically. 

In this paper, the authors used a 35-antibody panel to provide a detailed immune landscape of lung biopsies from patients with fatal COVID-19 infection. Using a bespoke suite of mathematical tools, the authors uncovered a specific association between a highly inflammatory cluster of immature neutrophils, CD8 T-cells and regenerating lung stem cells in the most damaged areas of the lungs.

Neutrophils and T-cells are both types of immune cells. Neutrophils are part of the innate immune system and are one of the first responders in the immune response. T cells, on the other hand, are part of the adaptive immune system, providing a more specific response to infection than the neutrophils.

Circulating immature neutrophils are unusual but are known to be increased in the blood of patients with severe COVID-19. This study provides the first evidence of their presence in the lungs of those with severe COVID-19 and of their specific interaction with CD8 T-cells and lung stem cells. It highlights a potential role for immature neutrophils in lung injury and the possibility that this interferes with the ability of the lung to regenerate after severe viral infections. 

The study was a collaboration between immunobiologists in Oxford and the MRC TIDU, computer scientists at MRC WIMM Centre for Computational Biology and mathematicians at the Mathematical Institute. It demonstrates how mathematics combined with immunobiology and clinical understanding can be used to discover interactions and cellular networks which are otherwise impossible to see.

The authors provide an open-source computational pipeline called Spatial Omics Oxford Pipeline (SpOOx) and an enhanced version of a visual-analytical tool, Multi-Dimensional Viewer (MDV) software first developed at the WIMM, as a resource for spatial analysis. A brief overview is found in the video below:

Lead author Professor Ling-Pei Ho, co-lead of the NIHR Oxford Biomedical Research Centre (BRC) Respiratory Theme, said:

“This paper has been a testament to team science. It was an exciting time to see cellular patterns revealed by mathematical applications, which fitted biologically. Our next task is to tackle the functional side of this observation – how do immature neutrophil and CD8 T cells interact and what do they do to stem cells? We will expand these studies to other severe viral infections like influenza and severe lung diseases like idiopathic pulmonary fibrosis.”

Dr Praveen Weeratunga, one of the first authors, from MRC TIDU, said:

“This paper has the potential to have a wide reach. The  mathematical tools combined with precise and detailed identification of immune cells provides an unbiased method to uncover cellular connections in lung disease.”

Prof Helen Byrne from the Mathematical Institute and Ludwig Institute for Cancer Research said: 

"This work really highlights the benefits of multidisciplinary science: we came together as a new team, learned to speak each other’s languages and generated insight into lung disease that wouldn’t have been possible otherwise."

This work was funded by the MRC TIDU, CAMS Oxford Institute, Oxford Medical Science Division COVID funds, and NIHR Oxford BRC.

Read the full paper here.

Recent stories

Immune sensor can detect viral infection by monitoring cell’s own RNA

A recent study by the Rehwinkel Group and collaborators reveals a new way the immune sensor MDA5 can recognise viral infection – not only through viral RNA, but by monitoring changes to the cell’s own RNA processing.

New technology helps decode the genetic changes behind disease

Researchers from the Milne, Hughes and Davies Groups have developed a new technology that can reveal new therapeutic targets from common genetic variants linked to disease.

Everyday DNA damage reveals a hidden weakness in some cancers

Researchers in the Chapman Group have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.

MRC WIMM researchers win Health x AI Hackathon with tool to tackle delays in patient care

Three MRC WIMM researchers have won a £5,000 prize at a Health x AI Hackathon held at Google’s London headquarters, after developing an AI-powered tool designed to identify delays in patient care.

Professor Marella de Bruijn receives MRC Programme Award

Congratulations to Professor de Bruijn, who has been awarded funding from the UKRI Medical Research Council to investigate how the first blood stem cells formed in the embryo acquire their exceptional regenerative potential, with the aim of informing future stem cell therapies.

Professor Bethan Psaila wins ISEH Janet Rowley Award

Congratulations to Professor Psaila, who has received the 2026 Janet Rowley Award from the International Society for Experimental Hematology, in recognition of her outstanding contributions in the field of experimental haematology.